The Utility of Point of Care Test for Soluble ST2 in Predicting Adverse Cardiac Events during Acute Care of ST-Segment Elevation Myocardial Infarction

<div>The distribution of the sST2 measured level (ng/mL) and median of 152.1 ng/mL as a cutoff point in subjects with STEMI. As many as 32 subjects have the sST2 level more than the upper measured limit (i.e., &gt;250 ng/mL), and 1 subject has sST2 level less than the lower measured limit (i.e., &lt;12.5 ng/mL).</div>

Cardiology Research and Practice

fig1

Figure 1

Figure 1: The Utility of Point of Care Test for Soluble ST2 in Predicting Adverse Cardiac Events during Acute Care of ST-Segment Elevation Myocardial Infarction 

Figure 1 | The Utility of Point of Care Test for Soluble ST2 in Predicting Adverse Cardiac Events during Acute Care of ST-Segment Elevation Myocardial Infarction 